Gateway Advisory’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Gateway Advisory’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-49,646	Closed	-$7.49M	–	63
2019 Q1	$7.49M	Buy	+49,646	New	+$7.14M	1.94%	11
2018 Q4	–	Sell	-52,466	Closed	-$8.31M	–	61
2018 Q3	$8.31M	Buy	+52,466	New	+$7.94M	2.19%	10
2015 Q2	–	Sell	-3,323	Closed	-$393K	–	42
2015 Q1	$393K	Buy	+3,323	New	+$376K	0.17%	38

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Gateway Advisory's FBT Position: Q2 2019 in Review

Gateway Advisory sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2019, closing a stake of 49,646 shares — an estimated $7.49M sold.

Gateway Advisory first reported a position in FBT in Q1 2015 and held it in 3 quarters. The position peaked at $8.31M in Q3 2018. 222 funds tracked by Wall St. Rank hold FBT as of Q2 2019.

Gateway Advisory reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2019 after selling out during the quarter.
Gateway Advisory sold 49,646 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2019, an estimated $7.49M.
Gateway Advisory first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2015 and held it in 3 quarters.
Gateway Advisory's First Trust NYSE Arca Biotechnology Index Fund position peaked at $8.31M in Q3 2018.
222 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2019.

Based on Gateway Advisory's 13F filing for Q2 2019, filed 30 Jul 2019.